First Merchants Corp Novartis Ag Transaction History

First Merchants Corp

$1.42 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$80.52 - $93.75 $202,507 - $235,781	-2,515 Closed	0 $0
Q4 2021 Jan 27, 2022	BUY	$79.7 - $88.13 $200,445 - $221,646	2,515 New	2,515 $220,000
Q3 2021 Oct 26, 2021	SELL	$81.78 - $95.14 $198,561 - $230,999	-2,428 Closed	0 $0
Q2 2021 Jul 26, 2021	SELL	$85.24 - $94.15 $50,376 - $55,642	-591 Reduced 19.58%	2,428 $222,000
Q1 2021 Apr 22, 2021	SELL	$83.5 - $98.47 $113,643 - $134,017	-1,361 Reduced 31.07%	3,019 $258,000
Q4 2020 Jan 28, 2021	SELL	$78.07 - $94.43 $39,035 - $47,215	-500 Reduced 10.25%	4,380 $414,000
Q3 2020 Oct 28, 2020	SELL	$82.14 - $91.0 $357,801 - $396,396	-4,356 Reduced 47.16%	4,880 $424,000
Q2 2020 Jul 23, 2020	SELL	$80.93 - $91.1 $35,851 - $40,357	-443 Reduced 4.58%	9,236 $807,000
Q1 2020 Apr 23, 2020	BUY	$70.67 - $99.01 $3,533 - $4,950	50 Added 0.52%	9,679 $798,000
Q4 2019 Jan 30, 2020	BUY	$84.35 - $95.37 $6,326 - $7,152	75 Added 0.79%	9,629 $912,000
Q3 2019 Oct 24, 2019	SELL	$85.54 - $94.26 $14,541 - $16,024	-170 Reduced 1.75%	9,554 $830,000
Q2 2019 Jul 25, 2019	BUY	$75.4 - $92.8 $14,627 - $18,003	194 Added 2.04%	9,724 $888,000
Q1 2019 Apr 25, 2019	BUY	$75.32 - $86.15 $35,777 - $40,921	475 Added 5.25%	9,530 $916,000
Q4 2018 Jan 31, 2019	SELL	$73.66 - $82.02 $3,683 - $4,101	-50 Reduced 0.55%	9,055 $777,000
Q3 2018 Oct 24, 2018	BUY	$66.94 - $77.43 $11,446 - $13,240	171 Added 1.91%	9,105 $784,000
Q2 2018 Jul 26, 2018	SELL	$64.91 - $73.36 $6,815 - $7,702	-105 Reduced 1.16%	8,934 $675,000
Q1 2018 Apr 26, 2018	BUY	$70.39 - $84.15 $7,039 - $8,415	100 Added 1.12%	9,039 $731,000
Q4 2017 Jan 30, 2018	BUY	$72.33 - $77.64 $61,480 - $65,994	850 Added 10.51%	8,939 $751,000
Q3 2017 Oct 31, 2017	BUY	$74.14 - $77.27 $599,718 - $625,037	8,089	8,089 $694,000

Others Institutions Holding NVS

# of Institutions

1,423

Shares Held

130M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $215B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Merchants Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Merchants Corp with notifications on news.

Account